Clinical Trial Update: Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining diurnal variation of exogenous peptide administration designed to mimic growth hormone pulsatility in Growth Hormone Def…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Growth Hormone Deficiency | Phase 2 | Status: COMPLETED